Method and instrumentation for spatial multiomics using SUMI-technology

US12286665B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12286665-B2
Application numberUS-202217588371-A
CountryUS
Kind codeB2
Filing dateJan 31, 2022
Priority dateFeb 4, 2021
Publication dateApr 29, 2025
Grant dateApr 29, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Microscopy imaging that allow for multiple mRNAs, proteins and metabolites to be spatially resolved at a subcellular level provides valuable molecular information which is a crucial factor for understanding tissue heterogeneity as for example within the tumor micro environment. The current invention describes a method (SUMI-Seq) which combines the use of Spatial Unique Molecular Identifier in situ sequencing and in vitro sequencing of rolonies derived from rolling circle amplification from padlock oligonucleotides targeting portion of RNA or cDNA transcript at a subcellular level with less limitation in the amount of transcripts and the length of the sequence that can be analyzed. Apart from padlocks oligonucleotides, the SUMI-Seq method can also be applied using circular oligonucleotides to spatially resolve proteins and metabolites to provide multiomics results.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for obtaining a spatial location and sequence information of a target sequence in a sample comprising at least one RNA or c-DNA strand comprising the steps; a. providing an oligonucleotide having 50-1000 nucleotides that are complementary to the at least one RNA or c-DNA strand of the sample; b. hybridizing the oligonucleotide at its 5′ and 3′ ends to complementary parts of the at least one RNA or c-DNA strand to create a padlock with a gap between the 5′ and the 3′ end of the padlock; c. filling the gap of the padlock with the complementary nucleotides as target sequence and ligate them to generate a single strand circular template; d. multiplying the single strand circular template by a polymerase capable of rolling circle amplification into a plurality of DNA concatemers thereby forming rolonies; wherein providing the oligonucleotide with at least one spatial unique molecular identifier (SUMI) comprising at least 2 nucleotides; e. determining the spatial location of the rolonies by in situ sequencing of the SUMI; f. collecting the rolonies after in situ sequencing and transfer them for in vitro sequencing; g. determining the sequence of the SUMIs and the target sequence by in vitro sequencing of the rolonies; and h. linking the target sequence of the rolonies with the spatial location obtained from in situ sequencing via the sequence of the SUMIs. 2. The method according to claim 1 , wherein the oligonucleotide comprises at least one primer region with 5 to 50 nucleotides for the rolling circle amplification. 3. The method according to claim 1 , wherein at least one sequencing primer region is located between the SUMI region and the 5′ and/or the 3′ ends of the oligonucleotide. 4. The method according to claim 1 , wherein rolling circle amplification (RCA) to generate rolonies for in situ sequencing is activated by light and/or heat. 5. The method according to claim 1 , wherein after in situ sequencing cells are subjected to single cell sequencing. 6. The method according to claim 1 , wherein the oligonucleotide comprises at least one barcode-tag comprising at least 2 nucleotides. 7. The method according to claim 1 , wherein the rolony transfer includes nucleotide fragmentation and/or targeted enrichment and/or amplification.

Assignees

Inventors

Classifications

  • Oligonucleotides as tagging agents for labelling antibodies · CPC title

  • General methods of protein analysis not limited to specific proteins or families of proteins · CPC title

  • Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • Signal amplification · CPC title

  • C12Q1/6804Primary

    Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12286665B2 cover?
Microscopy imaging that allow for multiple mRNAs, proteins and metabolites to be spatially resolved at a subcellular level provides valuable molecular information which is a crucial factor for understanding tissue heterogeneity as for example within the tumor micro environment. The current invention describes a method (SUMI-Seq) which combines the use of Spatial Unique Molecular Identifier in s…
Who is the assignee on this patent?
Miltenyi Biotec Bv & Co Kg
What technology area does this patent fall under?
Primary CPC classification C12Q1/6804. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).